Hap Trading, LLC Genetic Technologies LTD Call Options Transaction History

Hap Trading, LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2022 May 12, 2022	SELL	$0.0 - $0.0 $0 - $0	-16,200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.0 - $0.01 $0 - $162	16,200 New	16,200 $3,000

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $11.5M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.